Clinical Outcomes of Moderately Hypofractionated Concurrent Chemoradiotherapy for Newly Diagnosed Glioblastoma

Post-Operative Accelerated-Hypofractionated Chemoradiation With Volumetric Modulated Arc Therapy and Simultaneous Integrated Boost in Glioblastoma: A Phase I Study (ISIDE-BT-2)

(2021) Marica Ferro et al.   Frontiers in Oncology

Dose Escalated Radiotherapy for Glioblastoma Multiforme: An International Systematic Review and Meta-Analysis of 22 Prospective Trials

(2021) Raj Singh et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

HEDOS – a computational tool to assess radiation dose to circulating blood cells during external beam radiotherapy based on whole-body blood flow simulations

(2021) Jungwook Shin et al.   PHYSICS IN MEDICINE AND BIOLOGY

Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline

(2021) Nimish A. Mohile et al.   JOURNAL OF CLINICAL ONCOLOGY

Chemoradiation in elderly patients with glioblastoma from the multi-institutional GBM-molRPA cohort: is short-course radiotherapy enough or is it a matter of selection?

(2020) Chan Woo Wee et al.   JOURNAL OF NEURO-ONCOLOGY

Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy

(2020) Philippe Lambin et al.   SEMINARS IN RADIATION ONCOLOGY

Proton Therapy Reduces the Likelihood of High-Grade Radiation-Induced Lymphopenia in Glioblastoma Patients: Phase II Randomized Study of Protons vs. Photons

(2020) Radhe Mohan et al.   NEURO-ONCOLOGY

Low Lymphocyte Count Is Associated With Radiotherapy Parameters and Affects the Outcomes of Esophageal Squamous Cell Carcinoma Patients

(2020) Xin Wang et al.   Frontiers in Oncology

Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumab

(2020) Nalee Kim et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

(2020) Michael Weller et al.   Nature Reviews Clinical Oncology

Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon therapy

(2020) Nalee Kim et al.   RADIOTHERAPY AND ONCOLOGY

Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era

(2019) Hwa Kyung Byun et al.   Radiation Oncology

Clinical observation of lymphopenia in patients with newly diagnosed glioblastoma

(2019) Woo Jin Kim et al.   JOURNAL OF NEURO-ONCOLOGY

Efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme: a single-institution experience

(2019) Liangzhi Zhong et al.   Radiation Oncology

Validation and optimization of a web-based nomogram for predicting survival of patients with newly diagnosed glioblastoma

(2019) Nalee Kim et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma

(2018) Soumon Rudra et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial)

(2018) Supriya Mallick et al.   JOURNAL OF NEURO-ONCOLOGY

Current state of immunotherapy for glioblastoma

(2018) Michael Lim et al.   Nature Reviews Clinical Oncology

Gender-Based Cerebral Perfusion Differences in 46,034 Functional Neuroimaging Scans

(2017) Daniel G. Amen et al.   JOURNAL OF ALZHEIMERS DISEASE

Novel recursive partitioning analysis classification for newly diagnosed glioblastoma: A multi-institutional study highlighting the MGMT promoter methylation and IDH1 gene mutation status

(2017) Chan Woo Wee et al.   RADIOTHERAPY AND ONCOLOGY

Hypofractionated short-course radiotherapy in elderly patients with glioblastoma multiforme: an analysis of the National Cancer Database

(2017) Kimberley S. Mak et al.   Cancer Medicine

Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era

(2017) Erica Hlavin Bell et al.   JAMA Oncology

Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic Cancer

(2016) Aaron T. Wild et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma

(2016) Joe S. Mendez et al.   JOURNAL OF NEURO-ONCOLOGY

Clinical and Dosimetric Predictors of Acute Severe Lymphopenia During Radiation Therapy and Concurrent Temozolomide for High-Grade Glioma

(2015) Jiayi Huang et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Survival in Patients With Severe Lymphopenia Following Treatment With Radiation and Chemotherapy for Newly Diagnosed Solid Tumors

(2015) Stuart A. Grossman et al.   Journal of the National Comprehensive Cancer Network

Elderly patients aged 65–75 years with glioblastoma multiforme may benefit from long course radiation therapy with temozolomide

(2014) C. Gzell et al.   JOURNAL OF NEURO-ONCOLOGY

The Etiology of Treatment-related Lymphopenia in Patients with Malignant Gliomas: Modeling Radiation Dose to Circulating Lymphocytes Explains Clinical Observations and Suggests Methods of Modifying the Impact of Radiation on Immune Cells

(2013) Susannah Yovino et al.   CANCER INVESTIGATION

Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide

(2011) Stuart A. Grossman et al.   CLINICAL CANCER RESEARCH

Simultaneous Integrated Boost Intensity-Modulated Radiotherapy in Patients With High-Grade Gliomas

(2010) Kwan Ho Cho et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS